- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for EPE
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024
CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024.
KNW Stock Earnings: Know Labs Misses EPS for Q2 2024
KNW stock results show that Know Labs missed analyst estimates for earnings per share the second quarter of 2024.
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024
PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024
BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
SCWO Stock Earnings: 374Water Meets EPS for Q1 2024
SCWO stock results show that 374Water met analyst estimates for earnings per share the first quarter of 2024.
AQMS Stock Earnings: Aqua Metals Meets EPS for Q1 2024
AQMS stock results show that Aqua Metals met analyst estimates for earnings per share the first quarter of 2024.
ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024
ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024.
ATXI Stock Earnings: Avenue Therapeutics Misses EPS for Q1 2024
ATXI stock results show that Avenue Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
ELTX Stock Earnings: Elicio Therapeutics Beats EPS for Q1 2024
ELTX stock results show that Elicio Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
ATHA Stock Earnings: Athira Pharma Beats EPS for Q1 2024
ATHA stock results show that Athira Pharma beat analyst estimates for earnings per share the first quarter of 2024.
CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q1 2024
CGEM stock results show that Cullinan Oncology beat analyst estimates for earnings per share the first quarter of 2024.
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
PRFX Stock Earnings: PainReform Misses EPS for Q1 2024
PRFX stock results show that PainReform missed analyst estimates for earnings per share the first quarter of 2024.
KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024
KOD stock results show that Kodiak Sciences beat analyst estimates for earnings per share the first quarter of 2024.
MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024
MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the first quarter of 2024.
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024
IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
GTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024
GTBP stock results show that GT Biopharma beat analyst estimates for earnings per share the first quarter of 2024.
MBIO Stock Earnings: Mustang Bio Beats EPS for Q1 2024
MBIO stock results show that Mustang Bio beat analyst estimates for earnings per share the first quarter of 2024.
NTBL Stock Earnings: Notable Labs Misses EPS for Q1 2024
NTBL stock results show that Notable Labs missed analyst estimates for earnings per share the first quarter of 2024.
REPL Stock Earnings: Replimune Group Misses EPS for Q4 2024
REPL stock results show that Replimune Group missed analyst estimates for earnings per share the fourth quarter of 2024.
NCNA Stock Earnings: NuCana Beats EPS for Q1 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the first quarter of 2024.
SPEC Stock Earnings: Spectaire Holdings Misses EPS for Q1 2024
SPEC stock results show that Spectaire Holdings missed analyst estimates for earnings per share the first quarter of 2024.
9 – 10 of 240 results
